Clinical Trial 49394

Marlton, NJ 08053


A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of PRX012 in Alzheimer's Disease.

Qualified Participants Must:

• Be 60-85
• Have BMI between 18-32
• Be experiencing memory loss

Qualified Participants May Receive:

  • Compensation for time and travel
  • No insurance necessary and travel included

Available At:

Hassman Research Institute
30 Lake Center Drive Suite 100
Marlton, NJ 08053
View Clinic Location


If you or someone you care for is interested in participating and lives within 50 miles of the location shown, please complete the form below and click 'Submit'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.